Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?

BACKGROUND: Low muscle mass, or sarcopenia, predicts poorer treatment outcomes in breast cancer. Neoadjuvant chemotherapy is the main treatment to improve surgical outcomes for breast cancer, yet few studies have assessed the relationships between different chemotherapy regimens and sarcopenia. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Min Kyeong, Park, Seho, Park, Chang, Doorenbos, Ardith Z., Go, Jieon, Kim, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460139/
https://www.ncbi.nlm.nih.gov/pubmed/36063619
http://dx.doi.org/10.1016/j.breast.2022.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460139/
https://www.ncbi.nlm.nih.gov/pubmed/36063619
http://dx.doi.org/10.1016/j.breast.2022.08.009

Ejemplares similares